Evidence is lacking to show that screening children or adolescents prevents later cardiovascular disease.
Sponsoring Organization: U.S. Preventive Services Task Force (USPSTF)Background:
The increasing prevalence of dyslipidemia in children and adolescents — particularly multifactorial dyslipidemia due to adverse lifestyle factors — led the USPSTF to update its 2016 guideline on screening asymptomatic children and adolescents for lipid disorders, in which they concluded that evidence was insufficient to recommend screening for children and adolescents. (NEJM JW Pediatr Adolesc Med Sep 2016 and JAMA 2016; 316:645).
Recommendation:
As in 2016, the USPSTF found insufficient evidence to recommend for or against screening for lipid disorders using a serum lipid panel (I statement). The Task Force addressed only routine screening, and not “targeted scre…
Reviewing Author
DisclosuresEditorial BoardsUpToDate
DisclosuresEditorial BoardsUpToDate